fbpx
March 8, 2022

Innovation in New Drug Approvals of 2019 Advances Patient Care Across a Broad Range of Diseases

Image By: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research Happy New Year! The beginning of a new year is always a rewarding time […]
March 8, 2022

FDA Harnesses Technology and Collaboration to Support Rare Disease Product Development

By: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner and Acting Chief Information Officer and Janet Maynard, M.D., M.H.S., Director, Office of Orphan Products Development Patients and […]
March 8, 2022

Shedding More Light on Sunscreen Absorption

Image By: Theresa M. Michele, M.D., Director, Office of Nonprescription Drugs, Office of New Drugs, Center for Drug Evaluation and Research, and David Strauss, M.D., Ph.D., […]
March 8, 2022

Serving Public Health Paramount in a Successful 2019 for FDA’s Generic Drug Program

Image By: Sally Choe, Ph.D., Director, Office of Generic Drugs, Center for Drug Evaluation and Research Safe, effective, high-quality generic drugs play a vital role in […]
March 8, 2022

Tennessee Technical Coatings Corp Issues Nationwide Voluntary Recall of Hand Sanitizer Isopropyl Alcohol Antiseptic 75% Due to Presence of Methanol

Summary Company Announcement Date: March 07, 2022 FDA Publish Date: March 07, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Product contains methanol Company […]
March 7, 2022

Fresenius Kabi Issues Voluntary Recall of Sodium Acetate Injection, USP Due to the Presence of Particulate Matter

Summary Company Announcement Date: March 07, 2022 FDA Publish Date: March 07, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to the presence […]
March 7, 2022

FY 2021 GDUFA Science and Research Report

The FY 2021 GDUFA Science and Research report provides detailed results for 13 areas of focus, each including a summary of research activities, research highlights, comprehensive […]
March 7, 2022

Learning from Patient Text Messaging to Optimize Opioid Prescribing and Reduce Misuse

CDER investigates the utility of a text messaging app to obtain patient-reported information that can help FDA improve opioid prescription guidelines for surgical patients. The Public […]
March 7, 2022

FDA Inspections of Outsourcing Facilities – 04/06/2022

On This Page Date: April 6, 2022 Time: 2:00 PM – 3:00 PM ET Visit CDER Small Business and Industry Assistance Page ABOUT THIS WEBINAR During […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0